Alvarez & Marsal looks to deepen India presence over the next year

Subscribe to enjoy similar stories.MUMBAI: Alvarez & Marsal (A&M) plans to scale up its corporate finance team in India and expand into new sectors, as the New York-based consulting firm positions itself to capture a rise in dealmaking and sustained capital inflows into the country, senior executives said.The expansion comes amid a shift in global investor strategy towards long-term capital deployment in India, driven by strong underlying fundamentals, high-growth prospects and elevated public market valuations that are pushing deal activity, including cross-border transactions.“We are building a highly sector-specialized corporate finance team, that integrates seamlessly with the firm’s other offerings,” said Mohit Khullar, managing director and head of corporate finance at Alvarez & Marsal India.The firm’s corporate finance practice currently spans consumer, industrials, healthcare and pharma, with the recent addition of Nitin Lath as managing director for the sector.“We will specialize within pharma, with a strong focus on Indian branded formulations, niche generics and speciality pharma, as well as CDMOs (contract development and manufacturing organization) and APIs (active pharmaceutical ingredients),” Lath said. “The pharma industry is undergoing a period of transformation, with several players re evaluating their business models and actively pursuing large M&A opportunities, including cross border transactions across the US and Europe.”Khullar said the firm will also expand into additional sectors such as financial services and technology in the coming months.

“We continue to invest in talent. We are currently a 40-member team with four managing directors (MD), and as we build out these sectors, we expect to add